Autosomal dominant medullary cystic kidney disease with or without hyperuricemia: genes and variants
Explore variant evidence for Autosomal dominant medullary cystic kidney disease with or without hyperuricemia across 2 analyzed proteins (UMOD, MUC1). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia
UMOD: Uromodulin
It is secreted by thick-ascending-limb cells into urine, where it contributes to salt handling, urinary defense, and protection against kidney stones. Dominant pathogenic variants cause autosomal dominant tubulointerstitial kidney disease, while common regulatory variants influence kidney-function and hypertension risk.
3 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in UMOD have source records linked to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia. Association strength is not clinical gene validity.
MUC1: Mucin-1
It forms a heavily glycosylated protective barrier on the apical surface of many epithelia and also participates in intracellular signaling. A specific frameshift mechanism causes autosomal dominant tubulointerstitial kidney disease, while overexpression and abnormal glycosylation are common in carcinomas.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MUC1 have source records linked to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| UMOD C106Y | 106 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| UMOD A461E | 461 | ZP | Pathogenic / likely pathogenic (★★) |
| UMOD C137W | 137 | EGF-like 3 | Pathogenic / likely pathogenic |
Same protein, different disease
- Familial juvenile hyperuricemic nephropathy also has ClinVar records linked to UMOD variants; they fall mostly in different places as the Autosomal dominant medullary cystic kidney disease with or without hyperuricemia variants (53 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia
- Familial juvenile hyperuricemic nephropathy, also linked to UMOD
- Kidney disorder, also linked to UMOD
Frequently asked questions
Which genes have records linked to Autosomal dominant medullary cystic kidney disease with or without hyperuricemia?
This view contains 2 analyzed proteins: UMOD, MUC1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 8 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center